DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

BioSmart Co.,Ltd.

KOSDAQ:A038460 Stock Report

Market Cap: ₩72.7b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

BioSmartLtd Past Earnings Performance

Past criteria checks 5/6

BioSmartLtd has been growing earnings at an average annual rate of 38.1%, while the Tech industry saw earnings growing at 22.7% annually. Revenues have been growing at an average rate of 17.3% per year. BioSmartLtd's return on equity is 9.3%, and it has net margins of 2.4%.

Key information

38.10%

Earnings growth rate

34.01%

EPS growth rate

Tech Industry Growth-2.85%
Revenue growth rate17.26%
Return on equity9.25%
Net Margin2.40%
Last Earnings Update30 Jun 2026

Recent past performance updates

Analysis Article • Mar 26

Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story

We didn't see BioSmart Co.,Ltd.'s ( KOSDAQ:038460 ) stock surge when it reported robust earnings recently. We looked...

Recent updates

Analysis Article • Feb 02

What BioSmart Co.,Ltd.'s (KOSDAQ:038460) 44% Share Price Gain Is Not Telling You

BioSmart Co.,Ltd. ( KOSDAQ:038460 ) shares have continued their recent momentum with a 44% gain in the last month...
Analysis Article • Dec 15

BioSmart Co.,Ltd.'s (KOSDAQ:038460) Shares Climb 44% But Its Business Is Yet to Catch Up

BioSmart Co.,Ltd. ( KOSDAQ:038460 ) shares have had a really impressive month, gaining 44% after a shaky period...
Analysis Article • Apr 23

The Market Lifts BioSmart Co.,Ltd. (KOSDAQ:038460) Shares 33% But It Can Do More

BioSmart Co.,Ltd. ( KOSDAQ:038460 ) shareholders have had their patience rewarded with a 33% share price jump in the...
Analysis Article • Apr 09

Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Nov 13

BioSmart Co.,Ltd. (KOSDAQ:038460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

The BioSmart Co.,Ltd. ( KOSDAQ:038460 ) share price has fared very poorly over the last month, falling by a substantial...
Analysis Article • Oct 14

Here's Why We Think BioSmartLtd (KOSDAQ:038460) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Aug 01

BioSmartLtd (KOSDAQ:038460) Seems To Be Using A Lot Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Jun 15

BioSmart Co.,Ltd. (KOSDAQ:038460) Might Not Be As Mispriced As It Looks After Plunging 26%

The BioSmart Co.,Ltd. ( KOSDAQ:038460 ) share price has softened a substantial 26% over the previous 30 days, handing...
Analysis Article • May 02

Here's Why BioSmartLtd (KOSDAQ:038460) Has A Meaningful Debt Burden

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Apr 11

Further Upside For BioSmart Co.,Ltd. (KOSDAQ:038460) Shares Could Introduce Price Risks After 52% Bounce

The BioSmart Co.,Ltd. ( KOSDAQ:038460 ) share price has done very well over the last month, posting an excellent gain...
Analysis Article • Mar 26

Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story

We didn't see BioSmart Co.,Ltd.'s ( KOSDAQ:038460 ) stock surge when it reported robust earnings recently. We looked...
Analysis Article • Mar 09

Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Feb 16

Returns On Capital At BioSmartLtd (KOSDAQ:038460) Paint An Interesting Picture

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Analysis Article • Jan 29

Declining Stock and Decent Financials: Is The Market Wrong About BioSmart Co.,Ltd. (KOSDAQ:038460)?

It is hard to get excited after looking at BioSmartLtd's (KOSDAQ:038460) recent performance, when its stock has...
Analysis Article • Jan 11

BioSmartLtd (KOSDAQ:038460) Shareholders Have Enjoyed A 51% Share Price Gain

BioSmart Co.,Ltd. ( KOSDAQ:038460 ) shareholders might be concerned after seeing the share price drop 26% in the last...
Analysis Article • Dec 23

BioSmart Co.,Ltd. (KOSDAQ:038460) Looks Interesting, And It's About To Pay A Dividend

BioSmart Co.,Ltd. ( KOSDAQ:038460 ) is about to trade ex-dividend in the next four days. Ex-dividend means that...
Analysis Article • Dec 17

Does BioSmart Co.,Ltd. (KOSDAQ:038460) Have A Place In Your Dividend Portfolio?

Dividend paying stocks like BioSmart Co.,Ltd. ( KOSDAQ:038460 ) tend to be popular with investors, and for good reason...
Analysis Article • Nov 29

These 4 Measures Indicate That BioSmartLtd (KOSDAQ:038460) Is Using Debt Extensively

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Revenue & Expenses Breakdown

How BioSmartLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A038460 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 26562,67813,48856,883866
31 Mar 26515,82011,44858,335603
31 Dec 25482,7769,00959,626693
30 Sep 25475,0317,21557,640794
30 Jun 25468,6061,72459,641734
31 Mar 25477,902-2,20859,749766
31 Dec 24484,31012759,072680
30 Sep 24477,3377,12857,621959
30 Jun 24472,3108,96058,929966
31 Mar 24464,37719,48261,6501,120
31 Dec 23456,16417,90764,1401,341
30 Sep 23451,6934,46465,8881,468
30 Jun 23430,6186,12165,3301,607
31 Mar 23409,3442,03864,3971,320
31 Dec 22391,82272162,7031,168
30 Sep 22332,8562,35460,209386
30 Jun 22287,7361,08458,968225
31 Mar 22237,7882,90956,485327
31 Dec 21189,1831,39256,413427
30 Sep 21184,940-5,44058,507804
30 Jun 21175,807-6,89158,0591,051
31 Mar 21167,868-9,99057,8301,088
31 Dec 20166,429-8,73755,5911,029
30 Sep 20166,3953,24756,345930
30 Jun 20167,21219,93054,695690
31 Mar 20165,73220,84252,595569
31 Dec 19158,96822,14749,542477
30 Sep 19151,42618,04645,517412
30 Jun 19143,9274,64641,389524
31 Mar 19129,5296,74435,709534
31 Dec 18117,7335,13531,412534
30 Sep 18103,1088,64525,604565
30 Jun 1892,4987,69121,079384
31 Mar 1887,4895,58518,848255
31 Dec 1780,4334,82616,992168
30 Sep 1779,5132,59415,37592
30 Jun 1774,7801,69714,28449
31 Mar 1768,02749513,09373
31 Dec 1662,99061911,90179
30 Sep 1658,8151,61911,97697
30 Jun 1655,9462,13412,127102
31 Mar 1655,2041,61912,10796
31 Dec 1554,1873,14811,61688
30 Sep 1550,6362,17810,69172

Quality Earnings: A038460 has high quality earnings.

Growing Profit Margin: A038460's current net profit margins (2.4%) are higher than last year (0.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A038460 has become profitable over the past 5 years, growing earnings by 38.1% per year.

Accelerating Growth: A038460's earnings growth over the past year (682.3%) exceeds its 5-year average (38.1% per year).

Earnings vs Industry: A038460 earnings growth over the past year (682.3%) exceeded the Tech industry 43.5%.


Return on Equity

High ROE: A038460's Return on Equity (9.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 08:44
End of Day Share Price 2026/09/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioSmart Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide